HELIX WAYFINDER
LIVE

Serial Number

99497202

Owner

Helix, Inc.

Attorney

DEVIN LEE JOSEPH LOOIJEN

First Use Date

Oct 1, 2025

Filing Date

Nov 14, 2025

Add to watchlist:

No watchlists yet
View on USPTO

HELIX WAYFINDER Trademark

Serial Number: 99497202

HELIX WAYFINDER is a trademark filed by Helix, Inc. on November 14, 2025. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Helix, Inc.

400 S El Camino Real
San Mateo, CA 94402

Entity Type: 03

Trademark Details

Filing Date

November 14, 2025

Registration Date

Not Registered

First Use Anywhere

October 1, 2025

First Use in Commerce

October 1, 2025

Goods & Services

(Based on Use) Medical and scientific research information in the field of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, and pharmacogenomics; Biomedical research services; Scientific research consulting in the field of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, and pharmacogenomics; Scientific research and development; DNA analysis services for scientific research purposes; Providing scientific research information in the field of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, and pharmacogenomics; Scientific research in the field of genetics; Providing medical research information in the field of genetics; Providing scientific research information in the field of genetics; Research and development services in the field of genomics; Biomedical research in the field of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, and pharmacogenomics; Scientific research in the field of genetics and genetic engineering; Providing information about medical research in the field of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, and pharmacogenomics; Scientific research consulting in the field of artificial intelligence (AI) for use in genetics research (Based on Intent to Use) Providing an on-line searchable database in the field of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, and pharmacogenomics for scientific research purposes; Providing temporary use of on-line non-downloadable cloud computing software for clinical interpretation of genetic variants; Platform as a service (PAAS) featuring computer software platforms for storing, managing, analyzing, sharing, distributing, referencing, monitoring and integrating genetic information using Artificial Intelligence (AI); Software as a service (SAAS) services featuring software using artificial intelligence (AI) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, interpreting genomic data, and analyzing genomic information in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics; Providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence (AI) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, interpreting genomic data, and analyzing genomic information in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics; Providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence (AI) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, interpreting genomic data, and analyzing genomic information in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics

Providing health care information by electronic means; Medical testing for diagnostic or treatment purposes; Blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories

Filing History

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 23, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 23, 2026 XELR
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Mar 31, 2026 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Mar 31, 2026 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Mar 31, 2026 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Mar 31, 2026 CPEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 24, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 24, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 24, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 24, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Nov 14, 2025 MAFR
NEW APPLICATION ENTERED
Nov 14, 2025 NWAP